ArticleNeurocomputing2020
Deep Learning for Variational Multimodality Tumor Segmentation in PET/CT.
Article in Neurocomputing, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed.
- A rapid total-body PET imaging approach for pediatric patients using non-attenuation-corrected PET scans.EJNMMI physics · 2026Article
- Comparison of Automatic Segmentation and Preprocessing Approaches for Dynamic Total-Body 3D Pet Images with Different Pet Tracers.Journal of imaging informatics in medicine · 2026Article
- Research on Cancer Prediction Based on Feature Optimization and Multimodal Fusion.Health care science · 2025Article
- Anatomy guided modality fusion for cancer segmentation in PET CT volumes and images.Scientific reports · 2025Article
- Single center experience of the impact of artificial intelligence image analysis software on short-term prognosis of non-small cell lung cancer.Frontiers in oncology · 2025Article
- CoF-DResNet: Cancer Metastasis Recognition Network based on Dynamic Coordinated Metabolic Attention and Structural Attention.Current pharmaceutical biotechnology · 2025Article
- An adaptive and lightweight YOLOv5 detection model for lung tumor in PET/CT images.Scientific reports · 2024Article
- A Tumor Volume Segmentation Algorithm Based on Radiomics Features in FDG-PET in Lung Cancer Patients, Validated Using Surgical Specimens.Diagnostics (Basel, Switzerland) · 2024Article
- A review of deep learning-based reconstruction methods for accelerated MRI using spatiotemporal and multi-contrast redundancies.Biomedical engineering letters · 2024Review
- PET radiomics in lung cancer: advances and translational challenges.EJNMMI physics · 2024Review
- A Review of Machine Learning Approaches for Brain Positron Emission Tomography Data Analysis.Nuclear medicine and molecular imaging · 2024Review
- Empowering PET: harnessing deep learning for improved clinical insight.European radiology experimental · 2024Review
- Prediction of preoperative microvascular invasion by dynamic radiomic analysis based on contrast-enhanced computed tomography.Abdominal radiology (New York) · 2024Article
- Multi-modal tumor segmentation methods based on deep learning: a narrative review.Quantitative imaging in medicine and surgery · 2024Review
- PET/CT based cross-modal deep learning signature to predict occult nodal metastasis in lung cancer.Nature communications · 2023Article
- Generative Adversarial Networks in Medicine: Important Considerations for this Emerging Innovation in Artificial Intelligence.Annals of biomedical engineering · 2023Review
- Head and neck tumor segmentation convolutional neural network robust to missing PET/CT modalities using channel dropout.Physics in medicine and biology · 2023Article
- Review
- Research on Segmentation Technology in Lung Cancer Radiotherapy Based on Deep Learning.Current medical imaging · 2023Review
- A deep learning approach for automatic tumor delineation in stereotactic radiotherapy for non-small cell lung cancer using diagnostic PET-CT and planning CT.Frontiers in oncology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Positron emission tomography/computed tomography (PET/CT) imaging can simultaneously acquire functional metabolic information and anatomical information of the human body. How to rationally fuse the complementary information in PET/CT for accurate tumor segmentation is challenging. In this study, a novel deep learning based variational method was proposed to automatically fuse multimodality information for tumor segmentation in PET/CT. A 3D fully convolutional network (FCN) was first designed and trained to produce a probability map from the CT image. The learnt probability map describes the probability of each CT voxel belonging to the tumor or the background, and roughly distinguishes the tumor from its surrounding soft tissues. A fuzzy variational model was then proposed to incorporate the probability map and the PET intensity image for an accurate multimodality tumor segmentation, where the probability map acted as a membership degree prior. A split Bregman algorithm was used to minimize the variational model. The proposed method was validated on a non-small cell lung cancer dataset with 84 PET/CT images. Experimental results demonstrated that: 1). Only a few training samples were needed for training the designed network to produce the probability map; 2). The proposed method can be applied to small datasets, normally seen in clinic research; 3). The proposed method successfully fused the complementary information in PET/CT, and outperformed two existing deep learning-based multimodality segmentation methods and other multimodality segmentation methods using traditional fusion strategies (without deep learning); 4). The proposed method had a good performance for tumor segmentation, even for those with Fluorodeoxyglucose (FDG) uptake inhomogeneity and blurred tumor edges (two major challenges in PET single modality segmentation) and complex surrounding soft tissues (one major challenge in CT single modality segmentation), and achieved an average dice similarity indexes (DSI) of 0.86 ± 0.05, sensitivity (SE) of 0.86 ± 0.07, positive predictive value (PPV) of 0.87 ± 0.10, volume error (VE) of 0.16 ± 0.12, and classification error (CE) of 0.30 ± 0.12.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.